D.E. Shaw & Co
JAZZ icon

D.E. Shaw & Co’s Jazz Pharmaceuticals JAZZ Stock Holding History

D.E. Shaw & Co’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,000
Closed -$1.33M – 4975
2022
Q3 		$1.33M Hold
10,000
– – ﹤0.01% 3362
2022
Q2 		$1.56M Hold
10,000
– – ﹤0.01% 3287
2022
Q1 		$1.56M Sell
10,000
-24,620
-71% -$3.57M ﹤0.01% 3545
2021
Q4 		$4.41M Buy
34,620
+10,000
+41% +$1.31M ﹤0.01% 2521
2021
Q3 		$3.21M Buy
+24,620
New +$3.72M ﹤0.01% 2561
2021
Q2 		– Sell
-10,000
Closed -$1.64M – 4873
2021
Q1 		$1.64M Buy
+10,000
New +$1.65M ﹤0.01% 2752
2020
Q4 		– Sell
-21,200
Closed -$3.02M – 4026
2020
Q3 		$3.02M Sell
21,200
-11,000
-34% -$1.36M ﹤0.01% 2065
2020
Q2 		$3.55M Sell
32,200
-13,100
-29% -$1.45M ﹤0.01% 1929
2020
Q1 		$4.52M Buy
45,300
+11,500
+34% +$1.49M 0.01% 1544
2019
Q4 		$5.05M Buy
+33,800
New +$4.6M 0.01% 1727
2017
Q2 		– Sell
-17,000
Closed -$2.47M – 3448
2017
Q1 		$2.47M Sell
17,000
-6,800
-29% -$886K ﹤0.01% 1707
2016
Q4 		$2.6M Buy
23,800
+3,800
+19% +$423K ﹤0.01% 1794
2016
Q3 		$2.43M Hold
20,000
– – ﹤0.01% 1774
2016
Q2 		$2.83M Hold
20,000
– – 0.01% 1681
2016
Q1 		$2.61M Hold
20,000
– – ﹤0.01% 1698
2015
Q4 		$2.81M Buy
20,000
+10,000
+100% +$1.39M ﹤0.01% 1868
2015
Q3 		$1.33M Buy
+10,000
New +$1.72M ﹤0.01% 2407

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

D.E. Shaw & Co's JAZZ Position: Q1 2026 in Review

D.E. Shaw & Co increased its Jazz Pharmaceuticals (JAZZ) stake by 50% in Q1 2026, buying an estimated $17.3M and bringing the position to 298,090 shares worth $56.4M. The position accounts for 0.03% of the portfolio, ranked #607.

D.E. Shaw & Co first reported a position in JAZZ in Q2 2013 and has held it in 40 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • D.E. Shaw & Co held 298,090 shares of Jazz Pharmaceuticals worth $56.4M as of Q1 2026.
  • D.E. Shaw & Co bought 98,788 Jazz Pharmaceuticals shares in Q1 2026, an estimated $17.3M.
  • Jazz Pharmaceuticals made up 0.03% of D.E. Shaw & Co's portfolio in Q1 2026, its #607 holding.
  • D.E. Shaw & Co first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 40 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.